TP53 and Familial prostate cancer: While no prior studies have demonstrated that TP53 modulates CACNA1D expression to regulate SOCE, earlier research has shown that CACNA1D can influence SOCE in colon and prostate cancers, despite its conventional role as a voltage-gated Ca2+ channel [37,44].